Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

NCT07546695 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: Data Collection from medical records of from an already existing database "ONCOLOGICAL BREAST SURGERY DATABASE OF THE UNIVERSITY HOSPITAL OF BASEL" which was initiated in 2016.

Sponsor

University Hospital, Basel, Switzerland